.Asset supervisor TPG, which has assisted biotechs including Sionna Rehabs and Santa Clam Ana Bio, h...
.Merck & Co.'s TIGIT plan has actually experienced one more setback. Months after shuttering a pe...
.After a year described through pipe cuts, the variation of its chief executive officer as well as l...
.Cullinan Therapeutics was blown away enough with Port BioMed's bispecific invulnerable reactor that...
.In this week's episode of "The Top Line," we are actually diving right into Ferocious Biotech's ann...
.The confetti is still soaring from Eli Lilly's celebration celebrating the approval of Alzheimer's ...
.Accept to this week's Chutes & Ladders, our summary of notable management hirings, shootings as ...
.Observing a poor showing for Lykos Therapies' MDMA candidate for post-traumatic stress disorder at ...
.AN2 Therapies is actually re-thinking its company in reaction to dull midphase information, vowing ...
.Merck & Co. is spending $700 million beforehand to test Amgen in a blood stream cancer cells mar...